NPCE
NeuroPace, Inc.
Medical Devices · Healthcare · United States
12.30
close · 2026-10-30
value
34
cheaper than peers34
quality
5
stronger fundamentals5
ranked against
Medical Devices
value
quality
84 peerswide variation
Value inputs
| measure | company | vs peers |
| earnings yield, latest year | -5.4% | 55 |
| cash flow yield, 2 years ago | -4.7% | 54 |
| earnings yield, 1 year ago | -7.6% | 52 |
| cash flow yield, latest year | -2.7% | 49 |
| cash flow yield, 1 year ago | -4.3% | 48 |
| earnings yield, 2 years ago | -10.3% | 47 |
| cash flow yield, 3 years ago | -8.9% | 43 |
| earnings yield, 3 years ago | -15.5% | 40 |
| price to sales | 4.24× | 32 |
| price to book | 35.45× | 3 |
10 of 12 measures available
Quality inputs
| measure | company | vs peers |
| operating margin | -25.2% | 34 |
| revenue growth | -2.0% | 18 |
| return on equity | -111.4% | 16 |
| debt to equity | 487.5% | 6 |
4 of 4 measures available
Facts
| market cap | $422M |
| free cash flow | -$2.7M |
| employees | 220 |
| first trade | 2021-04-22 |
| next earnings | 2026-11-12 |
| fundamentals updated | 2026-08-11 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -0.66 | -0.93 | -1.27 | -1.91 |
| free cash flow | -$11.3M | -$18.3M | -$19.9M | -$37.5M |
| net income | -$21.5M | -$27.1M | -$33.0M | -$47.1M |
| revenue | $100.0M | $79.9M | $65.4M | $45.5M |